"Dub"bing a tumor suppressor pathway

4Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The autosomal recessive disease Fanconi anemia (FA) causes bone marrow failure and a hugely increased propensity to develop cancer. Cells from FA patients are prone to chromosome breakage, indicating that FA gene products are required to ensure genomic integrity. Most of the identified FA proteins are components of a nuclear complex whose principal function is to activate FANCD2 by monoubiquitination. Monoubiquitinated FANCD2 accumulates at sites of genome damage, where it probably functions to facilitate DNA repair. A recent paper in Molecular Cell (Nijman et al., 2005) reports the identification of an enzyme that is responsible for regulating the FA pathway by deactivating FANCD2.

Cite

CITATION STYLE

APA

Niedzwiedz, W., & Patel, K. J. (2005). “Dub”bing a tumor suppressor pathway. Cancer Cell. Cell Press. https://doi.org/10.1016/j.ccr.2005.01.018

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free